The three most promising proteins (CELSR2, FN1, and SPARCL1) were identified as potential therapeutic targets for atherosclerosis, while APOE, LPA, APOA5, TGFB1, and AGER also hold potential as drug targets for the disease. This evidence concerns the gene FN1 and atherosclerosis.